Theo Zimmermann

EUCAN Commercial Director CVRM l Rare Diseases l Market Access l AstraZeneca

Switzerland

About

• Regional Commercial Management Europe and Canada • Market Access Europe and Canada • Business Unit Management with P&L Responsibility • Sales Management (national / regional) • Financial Analysis and Management • Fluency in 6 European Languages

Experience

  • EUCAN Commercial Director CVRM at AstraZeneca

    Commercial Director Europe and Canada for: • FORXIGA / Dapagliflozin (Chronic Kidney Disease, Heart Failure, Type-2-Diabetes) • Future asset portfolio in Hypertension (u/rHTN and related additional indications) EUCAN Market Access Director (on assignment) for: • Pipeline assets in Biopharma

  • Product Management / Sales / Market Access at Bayer Pharmaceuticals

    • Local / global product manager (cardiovascular) • Sales representative (cardiovascular) • Market access manager (Switzerland)

  • Business Unit Director Rare Diseases and Immunology bei Takeda at Takeda

    • Rare Metabolic Diseases • Dermatology (HAE) • Rare Endocrinology • Immunology

  • Master of Business Administration at IMD business school

  • Business Unit Director Rare Diseases at Takeda

    • Rare Metabolic Diseases • Hereditary Angioedema • Endocrinology

  • Sales Manager Primary Care, Vaccines and Rare Diseases at MSD

    • Regional Sales Manager - Diabetes, Cardiology & Vaccines • National Sales Manager - Rare Diseases (Pulmonary Hyptertension)